JP2005501565A - Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ属細菌の分子識別 - Google Patents
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ属細菌の分子識別 Download PDFInfo
- Publication number
- JP2005501565A JP2005501565A JP2003525672A JP2003525672A JP2005501565A JP 2005501565 A JP2005501565 A JP 2005501565A JP 2003525672 A JP2003525672 A JP 2003525672A JP 2003525672 A JP2003525672 A JP 2003525672A JP 2005501565 A JP2005501565 A JP 2005501565A
- Authority
- JP
- Japan
- Prior art keywords
- staphylococcus
- sequence
- seq
- sequences
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000191940 Staphylococcus Species 0.000 title claims abstract description 95
- 101150090202 rpoB gene Proteins 0.000 claims abstract description 87
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 68
- 241000894007 species Species 0.000 claims abstract description 56
- 230000000295 complement effect Effects 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 49
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 49
- 239000002773 nucleotide Substances 0.000 claims abstract description 48
- 239000012634 fragment Substances 0.000 claims abstract description 43
- 230000001580 bacterial effect Effects 0.000 claims abstract description 33
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 16
- 229930010555 Inosine Natural products 0.000 claims abstract description 11
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims abstract description 11
- 229960003786 inosine Drugs 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000000523 sample Substances 0.000 claims description 76
- 241000894006 Bacteria Species 0.000 claims description 55
- 150000007523 nucleic acids Chemical class 0.000 claims description 35
- 102000039446 nucleic acids Human genes 0.000 claims description 33
- 108020004707 nucleic acids Proteins 0.000 claims description 33
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 30
- 230000003321 amplification Effects 0.000 claims description 29
- 238000009396 hybridization Methods 0.000 claims description 28
- 238000012163 sequencing technique Methods 0.000 claims description 23
- 241000191967 Staphylococcus aureus Species 0.000 claims description 20
- 108090000623 proteins and genes Proteins 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 241000191980 Staphylococcus intermedius Species 0.000 claims description 13
- 241001147695 Staphylococcus caprae Species 0.000 claims description 11
- 241001464905 Staphylococcus saccharolyticus Species 0.000 claims description 11
- 241000192099 Staphylococcus schleiferi Species 0.000 claims description 11
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 6
- 241000192085 Staphylococcus gallinarum Species 0.000 claims description 6
- 241001134656 Staphylococcus lugdunensis Species 0.000 claims description 6
- 241001033898 Staphylococcus equorum Species 0.000 claims description 5
- 241000191984 Staphylococcus haemolyticus Species 0.000 claims description 5
- 241000192087 Staphylococcus hominis Species 0.000 claims description 5
- 241000192086 Staphylococcus warneri Species 0.000 claims description 5
- 229940037649 staphylococcus haemolyticus Drugs 0.000 claims description 5
- 108091093088 Amplicon Proteins 0.000 claims description 4
- 241001251125 Staphylococcus aureus subsp. anaerobius Species 0.000 claims description 4
- 241001147687 Staphylococcus auricularis Species 0.000 claims description 4
- 241001147736 Staphylococcus capitis Species 0.000 claims description 4
- 241000191965 Staphylococcus carnosus Species 0.000 claims description 4
- 241000201871 Staphylococcus felis Species 0.000 claims description 4
- 241001147689 Staphylococcus kloosii Species 0.000 claims description 4
- 241000192101 Staphylococcus muscae Species 0.000 claims description 4
- 241000191978 Staphylococcus simulans Species 0.000 claims description 4
- 241000191973 Staphylococcus xylosus Species 0.000 claims description 4
- 229940037648 staphylococcus simulans Drugs 0.000 claims description 4
- 241000201854 Staphylococcus chromogenes Species 0.000 claims description 3
- 241000192097 Staphylococcus sciuri Species 0.000 claims description 3
- 238000006872 enzymatic polymerization reaction Methods 0.000 claims description 3
- 238000009007 Diagnostic Kit Methods 0.000 claims description 2
- 241000295644 Staphylococcaceae Species 0.000 claims 1
- 239000013615 primer Substances 0.000 description 57
- 108020004414 DNA Proteins 0.000 description 12
- 102000053602 DNA Human genes 0.000 description 12
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 11
- 101150085857 rpo2 gene Proteins 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 8
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 7
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 108091035707 Consensus sequence Proteins 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000001415 gene therapy Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000003155 DNA primer Substances 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 241001112695 Clostridiales Species 0.000 description 2
- 108010065152 Coagulase Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101100145480 Prochlorococcus marinus (strain SARG / CCMP1375 / SS120) rpoC2 gene Proteins 0.000 description 2
- 241000191982 Staphylococcus hyicus Species 0.000 description 2
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 101150109946 rpo1C gene Proteins 0.000 description 2
- 101150042391 rpoC gene Proteins 0.000 description 2
- 101150103066 rpoC1 gene Proteins 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000006303 Chaperonin 60 Human genes 0.000 description 1
- 108010058432 Chaperonin 60 Proteins 0.000 description 1
- 241000158508 Corynebacterium amycolatum Species 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 101100038183 Dictyostelium discoideum polr2a gene Proteins 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000193789 Gemella Species 0.000 description 1
- 101150023414 HSP60 gene Proteins 0.000 description 1
- 108010025076 Holoenzymes Proteins 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 101100091878 Plasmodium falciparum (isolate 3D7) rpoC2 gene Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241001147686 Staphylococcus arlettae Species 0.000 description 1
- 241000147121 Staphylococcus lentus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 206010044250 Toxic shock syndrome staphylococcal Diseases 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- -1 alkyl phosphates Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 101150022703 femA gene Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000012405 in silico analysis Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 101150100619 nuc gene Proteins 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000004708 ribosome subunit Anatomy 0.000 description 1
- 101150047139 rpo1N gene Proteins 0.000 description 1
- 101150029016 rpo3 gene Proteins 0.000 description 1
- 101150037064 rpoA gene Proteins 0.000 description 1
- 101150102864 rpoD gene Proteins 0.000 description 1
- 101150117326 sigA gene Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 208000017756 staphylococcal toxic-shock syndrome Diseases 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0111514A FR2829148B1 (fr) | 2001-09-06 | 2001-09-06 | Identification moleculaire des bacteries du genre staphylococcus |
| PCT/FR2002/003012 WO2003020972A1 (fr) | 2001-09-06 | 2002-09-05 | Identifaction moleculaire des bacteries du genre staphylococcus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501565A true JP2005501565A (ja) | 2005-01-20 |
| JP2005501565A5 JP2005501565A5 (enExample) | 2006-01-05 |
Family
ID=8867014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003525672A Pending JP2005501565A (ja) | 2001-09-06 | 2002-09-05 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ属細菌の分子識別 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7883870B2 (enExample) |
| EP (1) | EP1425420A1 (enExample) |
| JP (1) | JP2005501565A (enExample) |
| FR (1) | FR2829148B1 (enExample) |
| WO (1) | WO2003020972A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861743B1 (fr) * | 2003-11-04 | 2007-10-19 | Univ Aix Marseille Ii | Identification moleculaire des bacteries du genre corynebacterium |
| FI115637B (fi) * | 2003-12-19 | 2005-06-15 | Mobidiag Oy | Diagnostinen menetelmä hengitystieinfektioita aiheuttavien bakteerien osoittamiseksi ja tunnistamiseksi ja menetelmässä käyttökelpoinen alukeseos |
| WO2006111028A1 (en) * | 2005-04-21 | 2006-10-26 | Uti Limited Partnership | Pcr for mrsa sccmec typing |
| JP2010524454A (ja) | 2007-04-19 | 2010-07-22 | モレキュラー ディテクション インコーポレーテッド | 抗生物質耐性細菌の検出および分析のための方法、組成物、およびキット |
| US7811764B2 (en) * | 2007-08-14 | 2010-10-12 | University Of Rochester | Hybridization-based biosensor containing hairpin probes and use thereof |
| CN110157821B (zh) * | 2019-05-06 | 2020-08-28 | 浙江大学 | 一种用于人葡萄球菌检测的试剂盒 |
| KR102195998B1 (ko) * | 2019-09-27 | 2020-12-29 | 코스맥스 주식회사 | 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도 |
| KR102286076B1 (ko) * | 2019-09-27 | 2021-08-05 | 코스맥스 주식회사 | 스타필로코커스 갈리나룸 st-4 균주 및 그의 피부 상태 개선 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994066A (en) * | 1995-09-11 | 1999-11-30 | Infectio Diagnostic, Inc. | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| EP0966529A1 (en) * | 1996-11-25 | 1999-12-29 | Smithkline Beecham Corporation | Novel prokaryotic polynucleotides, polypeptides and their uses |
| KR100234975B1 (ko) * | 1997-07-28 | 1999-12-15 | 국윤호 | 마이코박테리아의 rpoB 유전자 분절을 표적으로 하는 PCR-RFLP에 의한 마이코박테리아 균종의 탐지 및 동정방법 |
| ES2290979T3 (es) * | 1997-12-15 | 2008-02-16 | Csl Behring Gmbh | Cebador marcado para uso en la deteccion de acidos nucleicos diana. |
| WO2001034809A2 (en) * | 1999-11-09 | 2001-05-17 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
-
2001
- 2001-09-06 FR FR0111514A patent/FR2829148B1/fr not_active Expired - Fee Related
-
2002
- 2002-09-05 WO PCT/FR2002/003012 patent/WO2003020972A1/fr not_active Ceased
- 2002-09-05 JP JP2003525672A patent/JP2005501565A/ja active Pending
- 2002-09-05 US US10/488,588 patent/US7883870B2/en not_active Expired - Fee Related
- 2002-09-05 EP EP02781366A patent/EP1425420A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1425420A1 (fr) | 2004-06-09 |
| US7883870B2 (en) | 2011-02-08 |
| US20040254360A1 (en) | 2004-12-16 |
| FR2829148A1 (fr) | 2003-03-07 |
| FR2829148B1 (fr) | 2004-10-15 |
| WO2003020972A1 (fr) | 2003-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5989821A (en) | Universal targets for species identification | |
| JP4579532B2 (ja) | メチシリン耐性黄色ブドウ球菌の検出と同定のための配列 | |
| US5437975A (en) | Consensus sequence primed polymerase chain reaction method for fingerprinting genomes | |
| US7883870B2 (en) | Molecular identification of Staphylococcus-genus bacteria | |
| KR101373756B1 (ko) | 황색포도상구균의 분자적 동정을 위한 프라이머 및 이를 이용한 황색포도상구균 동정 방법 | |
| EP1565573B1 (en) | Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used | |
| JP4717441B2 (ja) | 連鎖球菌属および関連する属の細菌の分子レベルの同定 | |
| Štěpán et al. | Identification of Staphylococcus aureus based on PCR amplification of species specific genomic 826 bp sequence derived from a common 44-kb Sma I restriction fragment | |
| JP5231206B2 (ja) | 核酸断片ならびにアシネトバクター属の種々の細菌種の分子同定による特異的検出法 | |
| WO2009090310A1 (en) | Method of detecting and identifying staphylococci | |
| US7659059B2 (en) | Method for detecting and/or identifying bacteria of the genus Staphylococcus | |
| JP4531317B2 (ja) | スピロヘータを検出するための一本鎖オリゴヌクレオチド、プローブ、プライマーおよび方法 | |
| US20070243530A1 (en) | Nucleic Acid Probes and Broad-Range Primers from Regions in Dna Directed Rna Polymerase Subunit B Genes, and Methods in Which They are Used | |
| EP1903116A1 (en) | Supplementation of sequence based typing of methicillin-resistant S. aureus (MRSA) by PCR-based grouping of SCCmec-elements; sequencing directly from the multiplex-PCR | |
| US20090253129A1 (en) | Identification of usa300 community-associated methicillin-resistant staphylococcus aureus | |
| Delvecchio et al. | Development of PCR-based assays for the detection and molecular genotyping of microorganisms of importance to biological warfare | |
| GRESS | VITO G. DELVECCHIO, RAJENDRA REDKAR, SHUQUI CHENG | |
| JP2003189870A (ja) | 病原微生物又は毒素の検出セット |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050708 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050708 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080610 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080903 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081224 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090318 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090416 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090508 |